139 related articles for article (PubMed ID: 6428844)
1. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.
DeFronzo RA; Simonson DC
Diabetes Care; 1984; 7 Suppl 1():72-80. PubMed ID: 6428844
[TBL] [Abstract][Full Text] [Related]
2. Low-dose oral glyburide reduces glucose production rates in patients with impaired fasting glucose.
Bavirti S; Tayek JA
Metabolism; 2003 Apr; 52(4):407-12. PubMed ID: 12701050
[TBL] [Abstract][Full Text] [Related]
3. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
[TBL] [Abstract][Full Text] [Related]
4. The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes.
Kolterman OG; Olefsky JM
Diabetes Care; 1984; 7 Suppl 1():81-8. PubMed ID: 6376033
[TBL] [Abstract][Full Text] [Related]
5. Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range.
Jani R; Molina M; Matsuda M; Balas B; Chavez A; DeFronzo RA; Abdul-Ghani M
Diabetes Care; 2008 Feb; 31(2):311-5. PubMed ID: 18000182
[TBL] [Abstract][Full Text] [Related]
6. Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy.
Taskinen MR; Bogardus C; Kennedy A; Howard BV
J Clin Invest; 1985 Aug; 76(2):637-44. PubMed ID: 3897287
[TBL] [Abstract][Full Text] [Related]
7. Non-insulin-dependent diabetes: 10-year outcome in relation to initial response to diet and subsequent sulfonylurea therapy.
Sönksen PH; Lowy C; Perkins JR; Lim HS
Diabetes Care; 1984; 7 Suppl 1():59-66. PubMed ID: 6376030
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
Simonson DC; Ferrannini E; Bevilacqua S; Smith D; Barrett E; Carlson R; DeFronzo RA
Diabetes; 1984 Sep; 33(9):838-45. PubMed ID: 6432610
[TBL] [Abstract][Full Text] [Related]
9. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
[TBL] [Abstract][Full Text] [Related]
10. [Hepatic and peripheral insulin resistance as a cause of hyperglycemia in non-insulin-dependent (type 2) diabetes mellitus: a review].
Bratusch-Marrain P; Waldhäusl W
Wien Klin Wochenschr; 1987 Apr; 99(7):211-6. PubMed ID: 3296467
[TBL] [Abstract][Full Text] [Related]
11. Correction of fasting hyperglycaemia with insulin or sulphonylurea lowers fasting ketone levels, but does not alter resting or post-glucose energy expenditure in non insulin dependent diabetes. Differences between the OGTT and the glucose clamp.
Boyd K; Boreham C; Andrews WJ; Hadden DR
Diabetes Res; 1991 Nov; 18(3):101-8. PubMed ID: 1841819
[TBL] [Abstract][Full Text] [Related]
12. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
14. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
[TBL] [Abstract][Full Text] [Related]
15. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W
J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
[TBL] [Abstract][Full Text] [Related]
16. Reduced glucose effectiveness as a feature of glucose intolerance: evidence in elderly type-2 diabetic subjects.
Viviani GL; Pacini G
Aging (Milano); 1999 Jun; 11(3):169-75. PubMed ID: 10476312
[TBL] [Abstract][Full Text] [Related]
17. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
18. Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects.
Abdul-Ghani MA; Matsuda M; DeFronzo RA
Diabet Med; 2008 Nov; 25(11):1289-94. PubMed ID: 19046218
[TBL] [Abstract][Full Text] [Related]
19. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
Mandarino LJ; Gerich JE
Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
[TBL] [Abstract][Full Text] [Related]
20. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA
Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]